42 results
8-K
EX-10.1
ELTX
Elicio Therapeutics Inc.
18 Mar 24
Entry into a Material Definitive Agreement
8:05am
of business) and has paid all taxes required to be paid by it and any other assessment, fine or penalty levied against it, to the extent that any … of the foregoing is due and payable, except for any such assessment, fine or penalty that is currently being contested in good faith or as would not have
8-K
EX-99.2
a6tejdif8zkl3oep7dxm
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
8-K
EX-10.1
g4zi8pig0kk foi6i
22 Dec 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-99.2
rckyqk 4sh
27 Sep 23
Other Events
5:41pm
8-K
EX-99.1
a2tzgfiaw5u4
7 Sep 23
Other Events
8:00am
8-K/A
EX-99.2
ar6gzru23fvxi5vq
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K/A
EX-99.1
j8ingbt20 urdxsph
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K
EX-99.5
am41kqh
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.3
u8cq3le0lpot1
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
gngrk3zgknbi zpq
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
EX-10.26
oy961n0y66cwoo3
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.34
yh39l 4jjh
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm